AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B ...Middle East

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced the...

Hence then, the article about ausperbio completes enrollment in two phase ii clinical trials of ahb 137 for chronic hepatitis b was published today ( Friday 19/09/2025 - 03:37 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B )

Also on site :

• ‘The Young and the Restless’ Star Dee Freeman Dead at 66
• “Esto es una recalibración”: el gabinete de Trump teme que nadie esté a salvo tras los despidos de Bondi y Noem
• New Uncharted game teased? Director post hints at franchise return